Trial intelligence / Profile preview

MWN109 in Weight Loss Maintenance in Non-Diabetic Participants With Overweight or Obesity

NCT07804797Phase 2Active, not recruiting

Sponsor
Shanghai Minwei Biotechnology Co., Ltd.
Start
Mar 2026
Primary completion
Sep 2026
Countries
1
01

Overview

A Phase 2 trial of MWN109 in Overweight, obesity, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Mar 2026; status: active, not recruiting.

02

Drugs

MWN109
03

Conditions

Overweightobesity

Beyond the preview

Go deeper on NCT07804797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07804797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call